Lebrikizumab Biosimilar – Research Grade
ichorbio’s Tralokinumab Biosimilar is for Research Use Only (RUO) and not for therapeutic use.
ichorbio’s Lebrikizumab Biosimilar is available in the following sizes:
Detects human IL-13. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Lebrikizumab. This product is for research use only.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Sterile, preservative-free, solution in PBS. BSA and Azide free.
>95% by SDS-PAGE
≤ 1.0 EU/mg as determined by the LAL method
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.